{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:57:07Z","timestamp":1790661427400,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.cca.2013.05.005","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T14:30:53Z","timestamp":1368455453000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo"],"prefix":"10.1016","volume":"424","author":[{"given":"Manoj Kumar","family":"Tembhre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthaprasad","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.05.005_bb0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0749.2004.00130.x","article-title":"On the etiology of contact\u2044occupational vitiligo","volume":"17","author":"Boissy","year":"2004","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cca.2013.05.005_bb0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1600-0749.2000.130106.x","article-title":"Higher plasma catecholamine and metabolite levels in the early phase of non-segmental vitiligo","volume":"13","author":"Cucchi","year":"2000","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cca.2013.05.005_bb0275","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/jid.1959.49","volume":"32","author":"Lerner","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cca.2013.05.005_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0749.2005.00244.x","article-title":"Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?","volume":"18","author":"Garbelli","year":"2005","journal-title":"Pigment Cell Res"},{"issue":"2","key":"10.1016\/j.cca.2013.05.005_bb0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cca.2013.05.005_bb0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0749.2006.00333.x","article-title":"A review and a new hypothesis for non immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Dell'Anna","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cca.2013.05.005_bb0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0006-2952(87)90345-5","article-title":"Mechanism of antitumoral activity of catechols in culture","volume":"36","author":"Picardo","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cca.2013.05.005_bb0040","first-page":"505","article-title":"Oxidative stress in the human epidermis","volume":"140","author":"Schallreuter","year":"2005","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.cca.2013.05.005_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cca.2013.05.005_bb0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","article-title":"A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?","volume":"16","author":"Gauthier","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cca.2013.05.005_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jdermsci.2005.06.004","article-title":"The genetic concept of vitiligo","volume":"39","author":"Zhang","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cca.2013.05.005_bb0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0190-9622(86)70021-2","article-title":"T cell profiles in vitiligo","volume":"14","author":"Grimes","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cca.2013.05.005_bb0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0190-9622(86)70085-6","article-title":"Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study","volume":"14","author":"Halder","year":"1986","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.cca.2013.05.005_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0781.2010.00563.x","article-title":"Reduction of skin-homing cytotoxic T cells (CD8+\u2013CLA+) in patients with vitiligo","volume":"27","author":"Antelo","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"10.1016\/j.cca.2013.05.005_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jdermsci.2011.03.004","article-title":"Detection of melanocyte autoantigens reacting with autoantibodies in vitiligo patients by proteomics","volume":"62","author":"Kim","year":"2011","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.cca.2013.05.005_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2010.01181.x","article-title":"Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo","volume":"20","author":"Kemp","year":"2011","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.cca.2013.05.005_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jid.2009.207","article-title":"Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library","volume":"130","author":"Waterman","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.cca.2013.05.005_bb0090","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coi.2009.09.011","article-title":"Regulatory T cells and inhibitory cytokines in autoimmunity","volume":"21","author":"Bettini","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.cca.2013.05.005_bb0280","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-\u03b2: the role of T regulator cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.cca.2013.05.005_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000067596","article-title":"The role of IL-10 and TGF-\u03b2 in the differentiation and effector function of T regulatory cells","volume":"129","author":"Levings","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.cca.2013.05.005_bb0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1523-1747.ep12480997","article-title":"Role of hair follicles in the repigmentation of vitiligo","volume":"97","author":"Cui","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cca.2013.05.005_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0749.1994.tb00049.x","article-title":"Melanocyte destruction and repopulation in vitiligo","volume":"7","author":"Norris","year":"1994","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.cca.2013.05.005_bb0115","doi-asserted-by":"crossref","first-page":"979258","DOI":"10.1155\/2009\/979258","article-title":"Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity","volume":"2009","author":"Kunz","year":"2009","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cca.2013.05.005_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","article-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, IFN-gamma released by peripheral mononuclear cells in patients with active vitiligo","volume":"108","author":"Yu","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cca.2013.05.005_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.cca.2013.05.005_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5154.92668","article-title":"Serum concentration of IL-6, IL-2, TNF-\u03b1, and IFN\u03b3 in vitiligo patients","volume":"57","author":"Singh","year":"2012","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.cca.2013.05.005_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin fluids of patients with vitiligo","volume":"21","author":"Tu","year":"1999","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/j.cca.2013.05.005_bb0140","first-page":"109","article-title":"Serum levels of the soluble interleukin-2 receptor in vitiligo patients in UAE","volume":"37","author":"Galadari","year":"2005","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.cca.2013.05.005_bb0145","first-page":"1085","article-title":"Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients","volume":"26","author":"Zailaie","year":"2005","journal-title":"Saudi Med J"},{"issue":"1","key":"10.1016\/j.cca.2013.05.005_bb0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Level of soluble interleukin-2 receptor in the sera and tissue fluids of patients with vitiligo","volume":"21","author":"Caixia","year":"1999","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.cca.2013.05.005_bb0155","first-page":"71","article-title":"Serum concentrations of interleukin-2 soluble receptor (IL-2 sR) in patients with vitiligo: relationship with type and extent of the disease","volume":"12","author":"Franczuk","year":"2004","journal-title":"Acta Dermatovenerol Croat"},{"issue":"3","key":"10.1016\/j.cca.2013.05.005_bb0160","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2133.2009.09217.x","article-title":"Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus","volume":"161","author":"Taher","year":"2009","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.cca.2013.05.005_bb0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaad.2008.09.048","article-title":"The role of helper and regulatory T cells in the pathogenesis of vitiligo","volume":"60","author":"Basak","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cca.2013.05.005_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cca.2013.05.005_bb0175","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2013.05.005_bb0180","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1-beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2013.05.005_bb0185","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cca.2013.05.005_bb0190","doi-asserted-by":"crossref","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cca.2013.05.005_bb0195","first-page":"81","article-title":"Expression of IL-17 and COX2 gene in peripheral blood leukocytes of vitiligo patients","volume":"10","author":"Esmaeili","year":"2011","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.cca.2013.05.005_bb0200","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of interleukin-17 in the pathogenesis of vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.cca.2013.05.005_bb0205","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/jimmunol\/186.7.3808","article-title":"Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"186","author":"Sakaguchi","year":"2011","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.cca.2013.05.005_bb0210","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.4049\/jimmunol.171.12.6323","article-title":"The regulatory T cell family: distinct subsets and their interrelation","volume":"71","author":"Jonuleit","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2013.05.005_bb0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.cca.2013.05.005_bb0220","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.cca.2013.05.005_bb0225","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.20032158","article-title":"Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II","volume":"199","author":"Kriegel","year":"2004","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.cca.2013.05.005_bb0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.cca.2013.05.005_bb0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4+ CD25+ T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.cca.2013.05.005_bb0240","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25+ high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cca.2013.05.005_bb0245","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cca.2013.05.005_bb0250","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"10.1016\/j.cca.2013.05.005_bb0255","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2011.07.018","article-title":"Circulating levels of T cell cytokines (IL-2, IL-4, IL-17 and TGF-\u03b2) in patients with vitiligo","volume":"66","author":"Khan","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cca.2013.05.005_bb0260","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI13863","article-title":"TGF-\u03b2\/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation","volume":"108","author":"Fiocchi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.05.005_bb0265","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/17826","article-title":"Inhibition of transforming growth factor-\/SMAD signaling by the interferon-\u03b3\/STAT pathway","volume":"397","author":"Ulloa","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.cca.2013.05.005_bb0270","doi-asserted-by":"crossref","first-page":"30226","DOI":"10.1074\/jbc.M005310200","article-title":"Tumor necrosis factor-\u03b2 \uf020inhibits transforming growth factor-\u03b2\/Smad signaling in human dermal fibroblasts via AP-1 activation","volume":"275","author":"Verrecchia","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811300199X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811300199X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:44:31Z","timestamp":1757861071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811300199X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":54,"alternative-id":["S000989811300199X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.05.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}